FOXO TECHNOLOGIES INC. (FOXO): Submission of Matters to a Vote of Security Holders
FOXO TECHNOLOGIES INC. (FOXO) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07 Submission of Matters to a Vote of Security Holders. On August 13, 2026, Rennova Health, Inc. (which is controlled by the Company’s CEO) (the “ Majority Stockholder ”), a shareholder representing a majority of the voting control of the Company, approved certain actions
How this was made
The 30-second read
Why it matters
A reverse split can change share price levels and trading behavior, and it may be interpreted by the market as an exchange-compliance or liquidity-management action. The company frames it as solely to facilitate an uplisting application.
Market read
Traders may reprice FOXO around corporate-action execution risk and uplisting probability, but the filing does not confirm the uplisting outcome.
What to watch
The exact split ratio is left to the board within the 1:50 to 1:1,000 range, and the timeline depends on the Schedule 14C mailing and FINRA processing, which can drive trading uncertainty.
Background
FOXO filed an 8-K (Item 5.07) describing written-consent approval of a reverse stock split and related steps to pursue listing on Nasdaq or NYSE American.
Ticker impact
FOXO disclosed a board-approved reverse stock split (1:50 to 1:1,000) to facilitate an uplisting to Nasdaq or NYSE American.
Short-term volatility risk around corporate-action mechanics and uplisting expectations; direction depends on market perception of listing prospects and dilution risk.
The 8-K is a primary SEC disclosure of a reverse split authorization tied to an uplisting application, but it does not provide financial results or a confirmed uplisting outcome.
Market effects
Limited sector read-through; reverse-split and uplisting mechanics are company-specific rather than industry-wide.
No clear regional spillover beyond US microcap listing dynamics.
Minimal global relevance; primarily affects US trading/liquidity for FOXO.
Counterpoint
If the uplisting is credible and improves institutional access, the reverse split could be viewed as a positive step rather than distress.
Key entities
- issuerFOXO Technologies Inc.
Company filing the 8-K and approving a reverse stock split to facilitate an uplisting.
- majority_stockholderRennova Health, Inc.
Majority stockholder controlled by the CEO, holding about 99.12% of voting rights, approved the actions via written consent.
- exchangeNasdaq Stock Market LLC / NYSE American LLC
Target senior national securities exchanges for the proposed uplisting.
- regulatorFINRA
Requires notice and processing under FINRA Rule 6490 in connection with the reverse split.
